Enhancement of LC3-Associated Efferocytosis for the Alleviation of Intestinal Inflammation

Scientists identified a novel compound, columbamine, which triggered LC3-associated phagocytosis and enhanced efferocytosis in an animal model of colitis to attenuate inflammation.